These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8477980)

  • 1. Omeprazole induction of cytochrome P-450IA2: the importance of selecting the appropriate human model.
    Watkins PB
    Hepatology; 1993 Apr; 17(4):748-50. PubMed ID: 8477980
    [No Abstract]   [Full Text] [Related]  

  • 2. P450IA2 and omeprazole.
    Farrell G
    Gastroenterology; 1992 May; 102(5):1822-3. PubMed ID: 1345326
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose dependent induction of CYP1A2 activity by omeprazole (Antra).
    Rost KL; Brösicke H; Scheffler M; Roots I
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):542-3. PubMed ID: 1490825
    [No Abstract]   [Full Text] [Related]  

  • 4. Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor.
    Daujat M; Peryt B; Lesca P; Fourtanier G; Domergue J; Maurel P
    Biochem Biophys Res Commun; 1992 Oct; 188(2):820-5. PubMed ID: 1280125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
    Curi-Pedrosa R; Daujat M; Pichard L; Ourlin JC; Clair P; Gervot L; Lesca P; Domergue J; Joyeux H; Fourtanier G
    J Pharmacol Exp Ther; 1994 Apr; 269(1):384-92. PubMed ID: 8169844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Aminobiphenyl-hemoglobin adduct formation as an index of in vivo N-oxidation by hepatic cytochrome P-450IA2.
    Hammons GJ; Dooley KL; Kadlubar FF
    Chem Res Toxicol; 1991; 4(2):144-7. PubMed ID: 1782342
    [No Abstract]   [Full Text] [Related]  

  • 7. Musk xylene is a novel specific inducer of cytochrome P-450IA2.
    Iwata N; Minegishi K; Suzuki K; Ohno Y; Kawanishi T; Takahashi A
    Biochem Biophys Res Commun; 1992 Apr; 184(1):149-53. PubMed ID: 1567420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole does not enhance the metabolism of phenacetin, a marker of CYP1A2 activity, in healthy volunteers.
    Xiaodong S; Gatti G; Bartoli A; Cipolla G; Crema F; Perucca E
    Ther Drug Monit; 1994 Jun; 16(3):248-50. PubMed ID: 8085279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin.
    Rost KL; Brösicke H; Brockmöller J; Scheffler M; Helge H; Roots I
    Clin Pharmacol Ther; 1992 Aug; 52(2):170-80. PubMed ID: 1505152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking.
    Kalow W; Tang BK
    Clin Pharmacol Ther; 1991 Jan; 49(1):44-8. PubMed ID: 1988240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-week treatment with omeprazole increases the metabolism of caffeine.
    Nousbaum JB; Berthou F; Carlhant D; Riche C; Robaszkiewicz M; Gouerou H
    Am J Gastroenterol; 1994 Mar; 89(3):371-5. PubMed ID: 8122647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions.
    Rizzo N; Padoin C; Palombo S; Scherrmann JM; Girre C
    Eur J Clin Pharmacol; 1996; 49(6):491-5. PubMed ID: 8706775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole.
    Shih H; Pickwell GV; Guenette DK; Bilir B; Quattrochi LC
    Hum Exp Toxicol; 1999 Feb; 18(2):95-105. PubMed ID: 10100022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducing effect of oxfendazole on cytochrome P450IA2 in rabbit liver. Consequences on cytochrome P450 dependent monooxygenases.
    Gleizes C; Eeckhoutte C; Pineau T; Alvinerie M; Galtier P
    Biochem Pharmacol; 1991 Jun; 41(12):1813-20. PubMed ID: 2039538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytochromes P450IA1 and P450IA2 and measurement of catalytic activities.
    Rodrigues AD; Prough RA
    Methods Enzymol; 1991; 206():423-31. PubMed ID: 1784227
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa.
    Buchthal J; Grund KE; Buchmann A; Schrenk D; Beaune P; Bock KW
    Eur J Clin Pharmacol; 1995; 47(5):431-5. PubMed ID: 7720765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoenzyme-specific induction of cytochromes P-450 in rat hepatocytes cultured in the presence of dimethylsulphoxide.
    Lindsay CK; Burke MD; Weaver RJ; Melvin WT; Hawksworth GM
    Biochem Soc Trans; 1990 Dec; 18(6):1212-3. PubMed ID: 2088874
    [No Abstract]   [Full Text] [Related]  

  • 18. [Omeprazole and the cytochrome P450 system of the liver].
    Petersen KU
    Leber Magen Darm; 1993 Sep; 23(5):186-92. PubMed ID: 8412467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytochrome P450 isoforms. Their genetic heterogeneity and induction by omeprazole.
    Farrell GC; Murray M
    Gastroenterology; 1990 Sep; 99(3):885-9. PubMed ID: 2199294
    [No Abstract]   [Full Text] [Related]  

  • 20. CYP1A2 and 2E1 expression in rat liver treated with combined inducers (3-methylcholanthrene and ethanol).
    Goasduff T; Menez JF; Dreano Y; Berthou F
    Biochem Biophys Res Commun; 1995 Jun; 211(2):497-503. PubMed ID: 7794261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.